NEW STEP BY STEP MAP FOR PHARMACEUTICAL MANUFACTURING FORMULATIONS

These types of carryover should not result in the carryover of degradants or microbial contamination which could adversely change the set up API impurity profile.Correct processes needs to be in place to detect contamination and decide the course of motion to become taken. Methods needs to be offered to ascertain the effect from the contamination a